Deborah A. Wing, MD
Associate Professor of
Clinical Obstetrics and Gynecology
Division Director
Division of Maternal Fetal Medicine
E-mail: dwing@uci.edu
Make an Appointment
Dr. Wing received her Medical Doctorate from Tulane University, School of Medicine, New Orleans, Louisiana. She continued her training in Obstetrics and Gynecology with subspecialty training in Maternal Fetal Medicine at the Women's and Children's Hospital of Los Angeles County and University of Southern California Medical Center, Los Angeles, California.
Dr. Wing is certified by the American Board of Obstetrics and Gynecology and has received subspecialty certification in Maternal Fetal Medicine.
Research Interests
Dr. Wing's areas of research include the physiology of human labor and delivery, focusing on cervical ripening and labor induction. Her clinical research trials have been conducted in both inpatient and outpatient settings and have used chemical and mechanical approaches. This research focus is timely in today's healthcare environment, addressing cost-effectiveness and innovation in antepartum/intrapartum care. She is considered a national, if not international, expert in the use of the agent known as misoprostol, for cervical ripening and labor induction in term pregnancies. She was the driving force in the research efforts that defined the "standard of care" in which the amount and dosing regimen were concluded.
Dr. Wing is currently participating in other projects evaluating differing approaches to cervical ripening and labor induction, including the use of an anti-progestational agent known as mifepristone and other approaches to the use of misoprostol for the same purpose. While known as an effective abortifacent, Dr. Wing has hypothesized that mifepristone will also be effective as an agent for cervical ripening and labor induction at term, which, if proven, will be a suitable oral agent for an outpatient approach.
Another research focus looks at different facets of urinary tract infection in pregnancy and the effects of these infections on newborns. She has conducted trials comparing outpatient to inpatient therapy for acute pyelonephritis in pregnancy, and other trials comparing the efficacy of differing antibiotics for upper urinary tract infection in pregnancy. Future investigation in this area will look at short-course therapies for uncomplicated urinary tract infections during pregnancy and preventative alternative medicine approaches.
|
Degree |
Major |
University |
Year |
Fellowship |
Maternal Fetal Medicine |
LA County/USC Medical Center |
1995 |
Internship/
Residency
|
Obstetrics and Gynecology |
LA County/USC Medical Center |
1993 |
M.D. |
Medicine |
Tulane University |
1989 |
B.A. |
Chemistry/Biology |
Pomona College, Claremont |
1985 |
Selected Publications
Wing DA, Tran S, Paul RH. Factors affecting the likelihood of successful induction after intravaginal misoprostol application for cervical ripening and labor induction. Am J Obstet Gynecol. 2002 Jun:186(6):1237-40. Discussion. 1240-3.
Mullin P, House M, Paul RH, Wing DA. A comparison of vaginally administered misoprostol with extra-amniotic saline solution infusion for cervical ripening and labor induction. Am J Obstet Gynecol 2002 Oct;187(4):847-52.
Millar LK, DeBuque L, Wing DA. Uterine contraction frequency and preterm birth associated with acute pyelonephritis in pregnancy. J Perinat Med. 2003;31(1):41-6.
Wing DA, Goharkhay N, Hanna M, Naidu YM, Kovacs BW, Felix JC. EP3-2 receptor mRNA expression is reduced and EP3-6 receptor mRNA expression is increased in gravid human myometrium. J Soc Gynecol Investig. 2003 Apr;10(3):124-9.
Pan V, Goharkhay N, Felix J, Wing DA. Role of fgl2 prothrombinase expression in gravid and non-gravid human myometrium. Am J Obstet Gynecol 2003;188:1057-62.
Goldberg AB, Wing DA. Induction of Labor: The Misoprostol Controversy (editorial). J Midwifery Women's Health. 2003 Jul-Aug;48(4):244-8.
